Skip to main content
NCBI home page
The Journal of Infectious Diseases logoLink to The Journal of Infectious Diseases
. 2019 Nov 29;221(10):1612–1622. doi: 10.1093/infdis/jiz628

Role of the Gonococcal Neisserial Heparin Binding Antigen in Microcolony Formation, and Serum Resistance and Adherence to Epithelial Cells

Evgeny A Semchenko 1, Tsitsi D Mubaiwa 1,✉, Christopher J Day 1, Kate L Seib 1,✉
PMCID: PMC7184908  PMID: 31781772

Abstract

The sexually transmitted infection gonorrhoea is on the rise worldwide and an increased understanding of the mechanisms of colonization and pathogenesis of Neisseria gonorrhoeae is required to aid development of new treatment and prevention strategies. In the current study, we investigate the neisserial heparin-binding antigen (NHBA) of N. gonorrhoeae and confirm its role in binding to several glycans, including heparin, and identify interactions of NHBA with both gonococcal and host cells. Furthermore, we report that a gonococcal nhba mutant displays decreased cell aggregation and microcolony formation, as well as reduced survival in human serum and reduced adherence to human cervical and urethral epithelial cells, relative to the wild-type strain. These data indicate that the gonococcal NHBA contributes to several aspects of the colonization and survival of N. gonorrhoeae and may be a target for new antimicrobial or vaccines.

Keywords: NHBA, neisserial heparin-binding Antigen, glycan, heparin, aggregation, microcolony, Neisseria gonorrhoeae, gonococcus, vaccine antigen, adherence, serum resistance

Neisserial heparin-binding antigen contributes to the colonization and survival of Neisseria gonorrhoeae. It binds to several glycans and is involved in bacterial cell aggregation, microcolony formation, survival in human serum, and adherence to human cervical and urethral epithelial cells.

Neisseria gonorrhoeae is an obligate human pathogen that causes approximately 106 million cases of the sexually transmitted infection gonorrhoea worldwide each year [1]. N. gonorrhoeae infects human mucosal surfaces, resulting in various clinical outcomes including local symptomatic disease (eg, cervicitis, urethritis, conjunctivitis), and occasionally disseminated disease [2]. Asymptomatic infections of the genital tract, rectum, or pharynx are common, and untreated genital tract infections can lead to severe sequelae, such as pelvic inflammatory disease, adverse pregnancy outcomes, neonatal complications, infertility, and increased risk of human immunodeficiency virus acquisition (reviewed in [3]).

The control of N. gonorrhoeae is a major public health challenge owing to the emergence of multidrug-resistant strains [4, 5]. Gonococcal strains with high-level resistance to expanded-spectrum cephalosporins, ceftriaxone and cefixime, as well as azithromycin and all other antibiotics routinely used to treat gonorrhoea, have been identified globally [6, 7]. This highlights the need for investigation of gonococcal pathogenesis to aid development of novel therapeutics and a vaccine.

The neisserial heparin-binding antigen (NHBA) is present in the 4 component meningococcal serogroup B vaccine (4CMenB; Bexsero) licensed to protect against invasive disease caused by Neisseria meningitidis [8], which is closely related to N. gonorrhoeae. The gonococcal homologue of NHBA is surface exposed and highly conserved in N. gonorrhoeae strains (>93% identity), shares 67% identity [9] with the 4CMenB NHBA, and is recognized by human serum samples from people vaccinated with 4CMenB [10].

The meningococcal NHBA has most extensively been studied in strain MC58 (expresses NHBA-3) and was named based on its ability to bind the glycosaminoglycan (GAG) heparin via an arginine-rich region (Arg region), and NHBA binding to heparin increases meningococcal resistance to serum [11] and interactions with heparan sulfate mediates binding to epithelial cells [12]. NHBA binds several other glycans, with the highest affinity binding to chondroitin sulfate [13]. The meningococcal NHBA is the target of several proteases, including human lactoferrin [11], kallikrein [14] and C3-convertase [15], as well as meningococcal NalP [11]. NalP cleaves NHBA after the arginine-rich region, and it has been speculated that hypervirulent strains of N. meningitidis that express NalP release a NHBA fragment that increases vascular permeability [16]. NHBA-2 also has increased expression at lower temperatures (32˚C vs 37˚C) [17] and plays a role in biofilm formation [18]. The gonococcal NHBA has not yet been characterized; however, N. gonorrhoeae does not express NalP [19], and its NHBA has a truncated Arg region [9] indicating that it may play a different role in N. gonorrhoeae than in N. meningitidis. In the current study, we examined the function of the gonococcal NHBA in order to describe its role in pathogenesis and support its potential use as a gonococcal therapeutic target or vaccine candidate.

METHODS

N. Gonorrhoeae Growth and Recombinant Techniques

N. gonorrhoeae 1291 was cultured on GC agar (Oxoid) or GC broth with 1% (vol/vol) IsoVitaleX (Becton Dickinson) at 32°C or 37°C, 5% carbon dioxide [20]. The nhba::kan mutant (ΔNHBA) and complemented (ΔNHBA_C) strains were generated as described in Supplementary Table 1. Expression of pilin, opacity (Opa) protein, porin, and lipooligosaccharide (LOS) was similar in the wild-type (WT), ΔNHBA, and ΔNHBA_C strains (Supplementary Figure 1). Recombinant His-tagged NHBA was expressed and purified as described elsewhere [10].

Western Blot Analysis, Enzyme-Linked Immunosorbent Assay, and Flow Cytometry

Western blot analysis of N. gonorrhoeae whole-cell lysates was performed as described elsewhere [21], with mouse anti-NHBA (see Supplementary Methods) and rabbit anti-NGAG_01228 [21]. Enzyme-linked immunosorbent assay (ELISA) of recombinant NHBA binding to whole-cell N. gonorrhoeae was performed after 30-minute incubation at room temperature, using horseradish peroxidase–conjugated His-tag antibody (Thermo) and following standard protocols [10, 22]. Flow cytometry was performed using a CyAn ADP cytometer (Beckman Coulter), as described elsewhere [21, 23], with bacteria (approximately 108 colony-forming units [CFUs]), anti-NHBA (1:200, 30 minutes), and Alexa Fluor 488–conjugated anti-mouse immunoglobulin G (1:200, 1 hour; Thermo). Binding of fluorescein isothiocyanate–labeled NHBA (100 µg/mL) to N. gonorrhoeae (approximately 107 CFUs) or to E6/E7-transformed primary human cervical epithelial (tCX) and urethral epithelial (tUEC) cells (approximately 5 × 105 cells) was measured after incubation for 20 minutes at 37°C.

Microscopy

Fluorescent microscopy was used to measure the interaction of NHBA (100 µg/mL) incubated with tCX cells (cultured on glass coverslips to full confluence) at 37°C for 20 minutes. Cells were washed 3 times to remove unbound proteins and fixed in formaldehyde (2.5% for 15 minutes). NHBA-542 (referred to herein as NHBANg)was detected using anti-NHBA (1:1000) [10] and Alexa Fluor 488–conjugated anti-mouse immunoglobulin G (1:200; Thermo). Cells were counterstained with Alexa Fluor 568 Phalloidin (Thermo) and DAPI. Glass coverslips were mounted on microscope slides using ProLong Gold Antifade Mountant (Thermo), images were captured on a Nikon A1R confocal microscope, and data were analyzed using NIS-Elements software version 1.2.3 (Nikon).

Gonococcal microcolony formation was investigated using tUEC cells incubated with approximately 1 × 106 CFUs at 37°C for 5 hours. Cell monolayers were washed 3 times (with Hanks’ balanced salt solution) to remove nonadherent bacteria and fixed for 30 minutes, and scanning electron microscopy (JCM-5000 NeoScope; JEOL) was performed as described elsewhere [24].

Glycan Binding

Glycan array experiments were performed with recombinant NHBA (1 µg), as described elsewhere [13, 25]. Surface plasmon resonance (BIAcore T200) was performed with NHBA (100 μg/mL) immobilized on flow cells 2–4 by amine coupling on series S CM5 sensor chips (GE Healthcare), as described elsewhere [13, 22]. Single-cycle kinetics was used to calculate the affinity (dissociation constant [KD]) of interactions with glycans run in 1:5 dilution series at concentrations between 100 μmol/L and 1 nmol/L

Functional Assays

Resistance of N. gonorrhoeae to serum-mediated killing was tested as described elsewhere [21], with approximately 104 CFUs incubated in 10% normal human serum for 60 minutes. Bacteria were preincubated with 6 µmol/L heparin for 30 minutes where indicated.

Gonococcal adherence to tCX and tUEC cells was assayed with approximately 105 CFUs for 1 hour as described elsewhere [23]. For adherence-blocking assays, cells were pretreated with recombinant gonococcal NHBA (1–100 µg/mL) or peanut agglutinin (PNA; 100 µg/mL; negative control that does not bind tCX [23]), before being infected with N. gonorrhoeae for 10 minutes. Adherence and serum survival assays were performed in triplicate on 3 occasions, and statistical analysis performed with analysis of variance and Student t tests.

RESULTS

Sequence Features and Expression of Gonococcal NHBA

The main NHBA variant expressed by N. gonorrhoeae strains is NHBA-542, which is present in >40% of gonococcal isolates in the PubMLST database, including strain 1291 [10]. NHBANg is 426 amino acids and contains sequence features similar to those described for the well-characterized NHBA-3 from N. meningitidis strain MC58 (referred to herein as NHBANm), including a lipobox motif and a polyglycine stretch in the N-terminal and an arginine-rich region in the central region of the protein (Figure 1A). However, there are several differences between NHBANg and NHBANm owing to insertions and deletions (Figure 1B). The N-terminal half of the gonococcal nhba gene has a 63–amino acid deletion compared with NHBA-3, and this is consistent in the major gonococcal variants (Supplementary Figure 2). The Arg region of NHBANg is truncated compared with NHBANm. This region is highly conserved between N. meningitidis strains [11] and between the major N. gonorrhoeae NHBA variants (Supplementary Figure 2; the variants shown are present in 94% of 3068 isolates [10]).

Figure 1.

Figure 1.

Open in a new tab

Neisserial heparin-binding antigen (NHBA) sequence features and expression. A, Schematic of Neisseria gonorrhoeae (Ng) strain 1291 NHBA and Neisseria meningitidis (Nm) strain MC58 NHBA proteins is shown, with the lipobox motif (gray box) and glycine stretch (black box) shown in the N-terminal, and the arginine-rich region (white box) shown in the central region of NHBA. The amino acid length of each protein is shown on the right. B, The N. gonorrhoeae and N. meningitidis NHBA proteins were aligned using ClustalW in MacVector software (version 17.0) (see Supplementary Methods). Identical amino acids are shown as dark gray vertical lines, mismatches light gray lines, and gaps as white. The amino acid sequences of the arginine-rich region in the N. gonorrhoeae and N. meningitidis NHBA proteins (boxed) and its flanking sequences are shown, with identical amino acids shaded gray and mismatches shown in white. The cleavage site of the meningococcal NalP upstream of the Arg-rich region, and human lactoferrin (hLf), kallikrein (hKl) and C3 convertase are shown. C, Western blot of whole-cell lysates of the N. gonorrhoeae 1291 wild-type (WT), NHBA knockout (ΔNHBA), and complemented (ΔNHBA_C) strains grown at 37˚C, using polyclonal anti-NHBA antibodies. Up-regulation of NHBA expression in the WT grown at 32˚C versus 37˚C is also shown. The periplasmic protein NGAG_01228 is shown as a loading control. D, Flow cytometry of whole cells of N. gonorrhoeae WT, ΔNHBA and ΔNHBA_C strains grown at 32˚C and 37˚C with the expression of NHBA on the cell surface being confirmed using polyclonal anti-NHBA antibody. The negative control is WT with secondary antibody only. Values represent geometric mean fluorescence.

To characterize NHBANg, a recombinant His-tagged protein NHBANg was generated in E. coli and polyclonal anti-NHBA antibodies raised in mice. In addition, an isogenic mutant of NHBA was generated by insertion of a kanamycin resistance cassette into the nhba gene in N. gonorrhoeae strain 1291 (ΔNHBA), and this mutant was complemented by reintroducing a single copy of nhba into the genome in trans (ΔNHBA_C). Western blot analysis of whole-cell lysates confirmed expression of NHBA in the WT strain, with a single band detected between 58 and 80 kDa by anti-NHBA sera. The complemented strain expressed levels of NHBA similar to those in the WT, whereas no NHBA expression was detected in ΔNHBA (Figure 1C and Supplementary Figure 1). NHBA was also detected on the surface of whole-cell N. gonorrhoeae WT and ΔNHBA_C strains by flow cytometry (Figure 1D). Growth of N. gonorrhoeae strains to midlog phase at 32°C and 37°C revealed that NHBANg expression is temperature regulated, with higher expression at lower temperatures (Figure 1C and 1D and Supplementary Figure 3).

Involvement of Gonococcal NHBA in Cell Aggregation and Microcolony Formation

To investigate the role of NHBANg in growth in vitro, the N. gonorrhoeae 1291 WT, ΔNHBA, and ΔNHBA_C strains were grown with gonococcal broth and agar. All strains had equivalent growth rates and maximal growth levels in terms of optical density (OD); however, the ΔNHBA mutant strain had significantly reduced settling rates compared with the WT and ΔNHBA_C strains (Figure 2A). Furthermore, when OD-equalized samples (OD at 600 nm [OD600], 1) were plated onto gonococcal agar, the ΔNHBA strain had approximately 3-fold higher viable CFU counts compared with the WT or ΔNHBA_C strains (Figure 2B).

Figure 2.

Figure 2.

Open in a new tab

Gonococcal neisserial heparin-binding antigen (NHBA) is involved in cell aggregation. A, Growth and settling curves of Neisseria gonorrhoeae 1291 wild-type (WT), NHBA knockout (ΔNHBA), and complemented (ΔNHBA_C) strains in gonococcal broth, with absorbance measured at an optical density at 600 nm (OD600). B, N. gonorrhoeae colony-forming units (CFUs) per milliliter in a culture at an OD600 of 1, before and after trypsinization (0.25% typsin for 5 minutes). The CFU counts of WT and ΔNHBA_C strains increased 2.6-fold and 2.4-fold, respectively, after trypsin treatment (both P < . 001), whereas the ΔNHBA CFU count was not affected (P = .31). *P < .05; †P < .001 (comparison to WT). C, Flow cytometric analysis of recombinant N. gonorrhoeae NHBA (NHBA)Ng binding to whole-cell N. gonorrhoeae (black represents N. gonorrhoeae only; white, N. gonorrhoeae plus labeled NHBANg). D, Whole-cell enzyme-linked immunosorbent assay titration curve showing binding of NHBANg to N. gonorrhoeae (black line). The antibody-only control curve (dotted line) indicates the absence of nonspecific interactions between whole-cell N. gonorrhoeae and the His-tag antibody.

Treatment of these samples with trypsin resulted in equalized CFU counts for all 3 strains (WT and ΔNHBA_C countable CFUs increased 2.6- and 2.4-fold, respectively, whereas the ΔNHBA CFU count was not affected) (Figure 2B), indicating that the phenotype was due to cell aggregation rather than a defect in cell separation. Gram stain analysis of the 3 stains with or without trypsin treatment confirmed the presence of cell aggregates in the untreated WT and ΔNHBA_C strains (Supplementary Figure 4A). Furthermore, Western blot analysis indicated that trypsin treatment digested NHBA from the bacteria surface but did not alter a periplasmic control protein (Supplementary Figure 4B). After this finding, the volume of ΔNHBA sample used in subsequent experiments was adjusted to equalize the CFU counts. Gonococcal pili and Opa proteins have been previously implicated in formation of bacterial aggregates, and phase-contrast microscopy confirmed that the WT, ΔNHBA, and ΔNHBA_C colonies were morphologically identical, in terms of piliation and opacity.

To determine whether NHBANg directly interacts with the gonococcal surface to facilitate aggregation, we used flow cytometry and ELISA with recombinant NHBANg. Flow cytometric analysis showed binding of the fluorescein isothiocyanate–labeled recombinant NHBANg to whole-cell N. gonorrhoeae (Figure 2C). This was confirmed using whole-cell ELISA, in which recombinant NHBANg bound N. gonorrhoeae in a concentration-dependent manner (Figure 2D).

To further study the role of NHBA in bacteria-bacteria interactions and in the formation of gonococcal aggregates, we examined the ability of ΔNHBA to form microcolonies. Unlike the WT or ΔNHBA_C strains, ΔNHBA was unable to form microcolonies on the surface of glass coverslip slides or tUEC monolayers after 5-hour growth (Figure 3). Biofilm assays were also performed to investigate whether the self-association properties of NHBANg play a role in the establishment of gonococcal biofilm. However, under static conditions over 24–26 hours, no difference in biofilm formation was observed for the WT, ΔNHBA, and ΔNHBA_C strains (data not shown).

Figure 3.

Figure 3.

Open in a new tab

Gonococcal neisserial heparin-binding antigen (NHBA) is involved in microcolony formation. Scanning electron microscopy shows Neisseria gonorrhoeae 1291 wild-type (WT), NHBA knockout (ΔNHBA), and complemented (ΔNHBA_C) strains grown for 5 hours on glass sides (top panel) or on human urethral epithelial cell monolayers on glass slides (bottom panel). Aggregates and microcolonies can be seen for the WT and ΔNHBA_C strains, whereas the ΔNHBA strain is seen as single colonies or diplococci. Images were acquired at a magnification of ×5000, and the scale bar at the bottom of each box represents 5 µm.

NHBANg Binding to Glycans With High Affinity

The glycan-binding profile of the gonococcal NHBA was determined using glycan array analysis with arrays that display 368 structures representative of glycans found on human cells (including isomers and/or glycans that have similar structure but differ in chain length, chemical linkage or spacer size). NHBANg bound to 39 glycan structures on the array (Supplementary Figure 5 and Supplementary Table 2), including the GAGs heparin, heparan sulfate, and chondroitin sulfate. NHBANg also bound multiple structures that contain a lacto-N-biose and N-acetyllactosamine core structure (ie, lacto-N-neotetraose [LNnT]) including their sialylated and fucosylated variants (ie, sLeX), as well as a limited set of N-acetylglucosamine, N-acetylgalactosamine, glucosyl, and mannosyl glycans.

To characterize the affinity of NHBANg-glycan interactions, surface plasmon resonance analysis was performed using selected GAGs (Figure 4A) and non-GAG glycans (Figure 4B) that were bound on the array. The highest calculated affinity of all tested interactions was with heparin (KD, 4.4 nmol/L), followed by chondroitin sulfate (KD, 73 nmol/L). GAG structures are highly heterogeneous, comprising repeating polysaccharides with various sulfation patterns. To determine whether NHBANg preferentially binds glycans with specific sulfation configuration, we performed experiments with 3 types of chondroitin sulfate (A, B, and C). NHBANg bound only chondroitin sulfate C (chondroitin 6-sulfate) and no concentration-dependent binding was observed for chondroitin sulfate A (chondroitin 4-sulfate) or chondroitin sulfate B (dermatan sulfate).

Figure 4.

Figure 4.

Open in a new tab

Gonococcal neisserial heparin-binding antigen (NHBA) binds to several glycans with high affinity. Surface plasmon resonance analysis of recombinant N. gonorrhoeae recombinant N. gonorrhoeae NHBA (NHBANg) (binding to glycosaminoglycans (GAGs) (A) and non-GAG glycans (B). The name, structure and sulfation patterns (S) of each glycan is shown, along with the dissociation constant (KD) of NHBANg binding to each glycan reported as mean (standard deviation). KD values are also shown for recombinant N. meningitidis NHBA (NHBA)Nm interactions [13], to enable comparison. NHBANm has higher affinity for β-Glc6P (KD, 0.056 [0.025] µmol/L). Results were analyzed using BIAcore T200 software 2.0.2. Abbreviations: NB, no concentration-dependent binding; NS, non sulfated.

We also show that NHBANg binds heparan sulfate, but with lower affinity (KD, 2.79 µmol/L). In terms of non-GAG glycans, NHBANg binds α2–6 sialylated pentasaccharide—LSTc (KD, 0.24 µmol/L)—with higher affinity than its isomer LSTb (KD, 2.26 µmol/L), and a nonsialylated variant of LNnT (KD, 4.89 µmol/L). Furthermore, NHBANg has 5-fold greater affinity for Lewis X (KD, 0.68 µmol/L) than for sialyl Lewis X (KD, 3.65 µmol/L). No concentration-dependent binding was observed for hyaluronan (a nonsulfated GAG) or H-disaccharide, which were not bound by NHBANg on the glycan array and were used as negative controls.

Gonococcal NHBA Binding to Epithelial Cells

NHBANm binds to epithelial cells through its Arg region via interactions with heparan sulfate proteoglycans [12]. To investigate whether NHBANg also interacts with epithelial cells, confocal microscopy and flow cytometric analysis were performed with recombinant NHBANg and tCX and tUEC cells. For confocal microscopy, recombinant NHBANg was incubated with tCX cells and detected using mouse anti-NHBA primary and Alexa Fluor 488 secondary antibodies. Binding of NHBANg to tCX cells was observed (Figure 5A, top left)) with the protein signal localized to the surface of cells (Figure 5A, bottom left). No nonspecific binding of the primary (Figure 5A, top right) or secondary (Figure 5A, bottom right) antibody to tCX cells was observed. Flow cytometric analysis further confirmed that NHBANg binds both tCX and tUEC cells (Figure 5B).

Figure 5.

Figure 5.

Open in a new tab

Gonococcal recombinant neisserial heparin-binding antigen (NHBANg) binds to epithelial cells. A, Confocal fluorescent images acquired under ×40 magnification of NHBANg binding to cervical epithelial (tCX) cells. Left, Extended focus (top left) and xyz (bottom left) images showing cross-sections of cells. Right, Antibody control (no NHBANg) images of untreated cells (top right) and cells treated with Recombinant N. gonorrhoeae NHBA (NHBANg) and secondary antibody (bottom right). Arrows indicate protein localizing on the cell surface. B, Flow cytometric analysis of binding of recombinant NHBANg to human tCX and urethral epithelial (tUEC) cells.

Contribution of NHBA to Gonococcal Serum Survival and Adherence to Epithelial Cells

To investigate the functional role of NHBANg interactions with glycans, gonococcal cells and human epithelial cells, we conducted serum survival and epithelial cell adherence assays. Serum survival assays performed with the WT, ΔNHBA, and ΔNHBA_C strains in 10% normal human serum (sublethal serum concentration for the WT strain) indicated that the ΔNHBA strain had approximately 3-fold reduced survival relative to the WT and ΔNHBA_C strains (Figure 6A). Pretreatment of gonococci with heparin increased survival of the ΔNHBA mutant strain to a level comparable to those of the WT and ΔNHBA_C strains.

Figure 6.

Figure 6.

Open in a new tab

Gonococcal neisserial heparin-binding antigen (NHBA) contributes to survival in human serum and adherence to human epithelial cells. A, Survival of Neisseria gonorrhoeae 1291 wild-type (WT), NHBA knockout (ΔNHBA), and complemented (ΔNHBA_C) strains after 60 minutes in 10% (vol/vol) normal human serum. ‘+ Heparin’ indicates that bacteria were preincubated with heparin prior to addition of normal human serum. Data represent the average percentage survival for triplicate samples as a percentage of the inoculum and are shown relative to the WT (results for the WT strain, set at 100%, are 5.5 × 104 colony-forming units [CFUs]). There was no significant difference in survival of the WT in serum according to the absence or presence of heparin. B, Adherence of N. gonorrhoeae to human cervical epithelia (tCX) and human urethral epithelial (tUEC) cells with N. gonorrhoeae 1291 WT, ΔNHBA, and ΔNHBA_C strains. C, Adherence of N. gonorrhoeae 1291 WT with tCX cells that were either untreated (no treatment) or pretreated with recombinant N. gonorrhoeae NHBA (NHBANg) (1–100 µg/mL) or peanut agglutinin (PNA) as a negative control (100 µg/mL). Data represent the average percent adherence for triplicate samples as a percentage of that for the inoculum and are shown relative to the WT; the results for the WT, set at 100%, are 1.1 × 105 (tCX) and 1.7 × 105 (tUEC) (B) and 6.5 × 104 adherent CFUs (C). Error bars represent standard deviations. Experiments were performed ≥3 times, and representative results are shown.*P < .05; †P < .01; ‡P < .001 (relative to untreated WT strain; 2-tailed Student t test).

To investigate the role of NHBANg in N. gonorrhoeae infection, we conducted in vitro infection assays with tCX and tUEC cells and the WT, ΔNHBA, and ΔNHBA_C strains. For infection assays with epithelial cells, the ΔNHBA mutant had 11-fold and 12-fold reduced adherence of tCX and tUEC cells, respectively, relative to the WT strain (Figure 6B). We also conducted adherence assays with cells that were pretreated with either recombinant NHBANg or negative control protein PNA. Gonococcal adherence to NHBANg-treated cells was reduced in a concentration-dependent manner (2.5- and 1.7-fold with 100 and 10 µg/mL of NHBANg, respectively), whereas treatment of cells with 100 µg/mL PNA, a negative control that does not bind cells, had no effect on adherence (Figure 6C).

DISCUSSION

The sexually transmitted infection gonorrhoea is a growing public health concern owing to rising rates of infection and increasing antimicrobial resistance. N. gonorrhoeae transmission, colonization, and pathogenesis are complex, multifactorial processes (reviewed in [26]), and an increased understanding of all stages of gonococcal infection is required to aid development of new treatment and prevention strategies. In the current study, we characterized the interactions of gonococcal NHBA with glycans, N. gonorrhoeae, and human epithelial cells, highlighting its involvement in microcolony formation, resistance to human serum, and adherence to epithelial cells.

NHBA was first identified in N. meningitidis during development of the meningococcal serogroup B vaccine 4CMenB [8, 11–15]. Despite a relatively high level of sequence identity between the gonococcal and meningococcal NHBA proteins (approximately 67% [10]), several differences between the NHBA sequences and the conditions encountered by the pathogenic Neisseria species prompted a detailed analysis of NHBA in N. gonorrhoeae. NHBA is more conserved in N. gonorrhoeae than in N. meningitidis [10], and in the current study we confirmed that the 63–amino acid deletion in the N-terminus and the truncated Arg region in N. gonorrhoeae are conserved in all major gonococcal NHBA variants.

In our glycan array analysis, recombinant NHBANg bound to 39 glycans, including GAGs, such as heparin, heparan sulfate, and chondroitin sulfate. Our group previously showed that NHBANm interacts with 28 glycans [13], and our surface plasmon resonance analysis confirmed that NHBANg and NHBANm bind ≥4 glycans in common (heparin, heparan sulfate, chondroitin sulfate, Glc-6P). However, a key difference between the proteins is that NHBANg has higher binding affinity for heparin, and lower affinity for chondroitin sulfate and glucose 6-phosphate than NHBANm. This is probably due to differences in the Arg region, known to be involved in NHBANm binding to GAGs [11, 12].

Furthermore, N. gonorrhoeae NHBANg but not NHBANm interacts with Lewis X and sialyl Lewis X antigens, LNnT and its sialylated variants on the glycan array, which can typically be found on the surface of host cells. Meningococcal cleavage of NHBANm by NalP releases a C-terminal fragment, C2 [11], which contains the Arg-rich region and increases vascular permeability [16]. In addition, human proteases lactoferrin and kallikrein cleave NHBANm downstream of the Arg region [11, 14], and the serum C3 convertase can cleave released NHBA C2 fragment, removing the Arg region and negating the toxic effect of protein on cells [15]. Because N. gonorrhoeae does not have a nalP gene [19], NHBANg would not be cleaved upstream of the Arg region. NHBANg is not cleaved by human lactoferrin (data not shown), and cleavage by kallikrein and C3 convertase have not been investigated. However, owing to the absence of NalP, even if NHBANg is cleaved by these human enzymes, the functional Arg region would remain attached to the gonococcal surface where it can mediate its roles associated with glycan binding.

The gonococcal ΔNHBA mutant strain displayed several phenotypes relative to the WT and ΔNHBA_C strains, including decreased survival in human serum, decreased aggregation and microcolony formation, and decreased adherence to tCX and tUEC cells. Although N. gonorrhoeae rarely causes disseminated disease, its ability to resist serum killing has been extensively studied and found to be mediated by factors including porin [27–29], LOS [30], and Opa protein [31], and that ability is relevant during mucosal infections, as serum and complement factors are present in the genital tract and other mucosal surfaces [32–34]. NHBANm is also involved in serum survival, with addition of heparin before the serum assay resulting in increased survival of the serum-sensitive, unencapsulated parent meningococcal strain but not the ΔNHBA mutant strain [11].

Heparin interacts with several complement factors [35], and heparin-mediated recruitment of complement regulatory proteins by NHBANm was proposed to be the mechanism of action for serum resistance [11]. We propose a similar mechanism of action for NHBANg, involving a higher level of recruitment of complement regulatory proteins to the surface of the WT strain relative to the ΔNHBA mutant. Even though NHBANg has higher affinity for heparin than NHBANm, additional gonococcal heparin-binding proteins play a role in serum resistance, such as Opa protein [31], which would account for the relatively high level of survival of the WT under the serum conditions tested, as well as the restoration of resistance of the gonococcal ΔNHBA mutant after addition of heparin to the assay.

Gonococcal adherence to the mucosal epithelium is the key first step in establishing an infection, and after initial adherence, N. gonorrhoeae colonization depends on the formation of robust bacterial aggregates and microcolonies on the epithelial cell surface (reviewed in [26]). Both initial adherence and microcolony formation are mediated by gonococcal factors, including type IV pili, Opa proteins, and LOS [36–39]. However, N. gonorrhoeae also form aggregates even in the absence of pili or Opa protein, suggesting the presence of unknown host factors that facilitate gonococcal aggregation [40].

We show that NHBANg plays a key role in establishing gonococcal infection, because the ΔNHBA mutant displayed decreased adherence to tCX and tUEC cells, as well as decreased aggregation and microcolony formation relative to the WT strain. Furthermore, recombinant NHBANg directly interacts with both epithelial cells and gonococcal cells, and NHBANg can block adherence to epithelial cells in a concentration-dependent manner. This is likely a result of NHBA interactions with host glycans on the epithelial cells, which mediate NHBANm interactions with Hec-1B and CHO-K1 cells [12]. The gonococcal NHBA is up-regulated at 32˚C versus 37˚C, consistent with NHBA regulation in N. meningitidis [17], which may be particularly relevant during adherence in the pharynx by these organisms, owing to the lower temperature of this niche.

The NHBANg-mediated interbacterium interactions, and the role of NHBANg in microcolony formation, may be facilitated by its interactions with LNnT, which is present on the surface of gonococcal cells as part of LOS [41]. Gonococcal microcolonies interact with host microvilli and lead to rearrangement of the host cytoskeleton and cortical plaque formation [42–46]. Microcolonies have also been implicated in increasing gonococcal resistance to antibiotics [40], and formation of bacterial aggregates is enhanced after exposure to seminal plasma, which influences bacterial transmission [47]. The formation of N. meningitidis aggregates is also important for resisting shear forces on the cell surface [48], which may also be important for N. gonorrhoeae. However, it is interesting to note that meningococcal NHBA has not been reported to be involved in aggregation to date [11, 12, 20].

In summary, we highlight the role of NHBA during several stages of gonococcal infection and pathogenesis. Our findings suggest that targeting NHBA-self and NHBA-host interactions may be a useful therapeutic and vaccine approach.

Supplementary Material

jiz628_suppl_Supplementary_Materials
Click here for additional data file. (3.3MB, pdf)

Notes

Acknowledgments. This publication made use of the Neisseria Multi Locus Sequence Typing website (https://pubmlst.org/neisseria/), developed by Keith Jolley and hosted at the University of Oxford; the development of this site has been funded by the Wellcome Trust and European Union.

Financial support. This work was supported by the Australian National Health and Medical Research Council (career development fellowship 1045235 to K. L. S. and project grants 1028326 to K. L. S. and 1099278 to C. J. D. and K. L. S.).

Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Presented in part: International Pathogenic Neisseria Conference, Asilomar, California, 23-28 September 2018.

References

  • 1. World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections—2008. Geneva, Switzerland: World Health Organization, 2012. [Google Scholar]
  • 2. Hook EW, Handsfield HH. Gonococcal infection in the adult. In: Holmes KK, ed. Sexually transmitted diseases. New York, NY: McGraw-Hill, 2008:627–45. [Google Scholar]
  • 3. Edwards JL, Jennings MP, Apicella MA, Seib KL. Is gonococcal disease preventable? the importance of understanding immunity and pathogenesis in vaccine development. Crit Rev Microbiol 2016; 42:928–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf Accessed 8 April 2018.
  • 5. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/. Accessed 8 April 2018.
  • 6. Unemo M, Bradshaw CS, Hocking JS, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis 2017; 17:e235–e79. [DOI] [PubMed] [Google Scholar]
  • 7. Public Health England. UK case of Neisseria gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone acquired abroad. 2018. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/694655/hpr1118_MDRGC.pdf. Accessed 8 April 2018.
  • 8. Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine 2012; 30 (suppl 2):B87–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Hadad R, Jacobsson S, Pizza M, et al. Novel meningococcal 4CMenB vaccine antigens—prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae. APMIS 2012; 120:750–60. [DOI] [PubMed] [Google Scholar]
  • 10. Semchenko EA, Tan A, Borrow R, Seib KL. The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae. Clin Infect Dis 2019; 69:1101–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Serruto D, Spadafina T, Ciucchi L, et al. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A 2010; 107:3770–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Vacca I, Del Tordello E, Gasperini G, et al. Neisserial heparin-binding antigen (NHBA) contributes to the adhesion of Neisseria meningitidis to human epithelial cells. PLoS One 2016; 11:e0162878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Mubaiwa TD, Hartley-Tassell LE, Semchenko EA, Day CJ, Jennings MP, Seib KL. The Bexsero Neisseria meningitidis serogroup B vaccine antigen NHBA is a high-affinity chondroitin sulfate binding protein. Sci Rep 2018; 8:6512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Pantano E, Cartocci E, Marchi S, et al. NHBA is processed by kallikrein from human saliva. PLoS One 2018; 14:e0203234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Di Fede M, Biagini M, Cartocci E, et al. Neisseria heparin binding antigen is targeted by the human alternative pathway C3-convertase. PLoS One 2018; 13:e0194662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Casellato A, Rossi Paccani S, Barrile R, et al. The C2 fragment from Neisseria meningitidis antigen NHBA increases endothelial permeability by destabilizing adherens junctions. Cell Microbiol 2014; 16:925–37. [DOI] [PubMed] [Google Scholar]
  • 17. Lappann M, Otto A, Brauer M, Becher D, Vogel U, Johswich K. Impact of moderate temperature changes on Neisseria meningitidis adhesion phenotypes and proteome. Infect Immun 2016; 84:3484–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Arenas J, Nijland R, Rodriguez FJ, Bosma TN, Tommassen J. Involvement of three meningococcal surface-exposed proteins, the heparin-binding protein NhbA, the alpha-peptide of IgA protease and the autotransporter protease NalP, in initiation of biofilm formation. Mol Microbiol 2013; 87:254–68. [DOI] [PubMed] [Google Scholar]
  • 19. Del Tordello E, Vacca I, Ram S, Rappuoli R, Serruto D. Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum. Proc Natl Acad Sci U S A 2014; 111:427–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Seib KL, Oriente F, Adu-Bobie J, et al. Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection. Vaccine 2010; 28:2416–27. [DOI] [PubMed] [Google Scholar]
  • 21. Semchenko EA, Day CJ, Seib KL. MetQ of Neisseria gonorrhoeae is a surface-expressed antigen that elicits bactericidal and functional blocking antibodies. Infect Immun 2017; 85:e00898-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Jen FEC, Semchenko EA, Day CJ, Seib KL, Jennings MP. The Neisseria gonorrhoeae methionine sulfoxide reductase (MsrA/B) is a surface exposed, immunogenic, vaccine candidate. Front Immunol 2019; 10:137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Semchenko EA, Everest-Dass AV, Jen FE, Mubaiwa TD, Day CJ, Seib KL. Glycointeractome of Neisseria gonorrhoeae: identification of host glycans targeted by the gonococcus to facilitate adherence to cervical and urethral epithelial cells. MBio 2019; 10:e01668-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Seib KL, Haag AF, Oriente F, et al. The meningococcal vaccine antigen GNA2091 is an analogue of YraP and plays key roles in outer membrane stability and virulence. FASEB J 2019; 33:12343–5. [DOI] [PubMed] [Google Scholar]
  • 25. Hartley-Tassell LE, Day CJ, Semchenko EA, et al. A peculiar case of Campylobacter jejuni attenuated aspartate chemosensory mutant, able to cause pathology and inflammation in avian and murine model animals. Sci Rep 2018; 8:12594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Quillin SJ, Seifert HS. Neisseria gonorrhoeae host adaptation and pathogenesis. Nat Rev Microbiol 2018; 16:226–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Ram S, Cullinane M, Blom AM, et al. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med 2001; 193:281–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Ram S, McQuillen DP, Gulati S, Elkins C, Pangburn MK, Rice PA. Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J Exp Med 1998; 188:671–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Ngampasutadol J, Ram S, Gulati S, et al. Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J Immunol 2008; 180:3426–35. [DOI] [PubMed] [Google Scholar]
  • 30. Gulati S, Cox A, Lewis LA, et al. Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci. Infect Immun 2005; 73:7390–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Chen T, Swanson J, Wilson J, Belland RJ. Heparin protects Opa+ Neisseria gonorrhoeae from the bactericidal action of normal human serum. Infect Immun 1995; 63:1790–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. McQuillen DP, Gulati S, Ram S, et al. Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. J Infect Dis 1999; 179:124–35. [DOI] [PubMed] [Google Scholar]
  • 33. Bischof P, Planas-Basset D, Meisser A, Campana A. Investigations on the cell type responsible for the endometrial secretion of complement component 3 (C3). Hum Reprod 1994; 9:1652–9. [DOI] [PubMed] [Google Scholar]
  • 34. Price RJ, Boettcher B. The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies. Fertil Steril 1979; 32:61–6. [DOI] [PubMed] [Google Scholar]
  • 35. Yu H, Munoz EM, Edens RE, Linhardt RJ. Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance. Biochim Biophys Acta 2005; 1726:168–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Steichen CT, Shao JQ, Ketterer MR, Apicella MA. Gonococcal cervicitis: a role for biofilm in pathogenesis. J Infect Dis 2008; 198:1856–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Zollner R, Oldewurtel ER, Kouzel N, Maier B. Phase and antigenic variation govern competition dynamics through positioning in bacterial colonies. Sci Rep 2017; 7:12151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Stein DC, LeVan A, Hardy B, Wang LC, Zimmerman L, Song W. Expression of opacity proteins interferes with the transmigration of Neisseria gonorrhoeae across polarized epithelial cells. PLoS One 2015; 10:e0134342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. LeVan A, Zimmerman LI, Mahle AC, et al. Construction and characterization of a derivative of Neisseria gonorrhoeae strain MS11 devoid of all opa genes. J Bacteriol 2012; 194:6468–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Wang LC, Litwin M, Sahiholnasab Z, Song W, Stein DC. Neisseria gonorrhoeae aggregation reduces its ceftriaxone susceptibility. Antibiotics 2018; 7:E48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Mandrell RE, Griffiss JM, Macher BA. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens: carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J Exp Med 1988; 168:107–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Lee SW, Higashi DL, Snyder A, Merz AJ, Potter L, So M. PilT is required for PI(3,4,5)P3-mediated crosstalk between Neisseria gonorrhoeae and epithelial cells. Cell Microbiol 2005; 7:1271–84. [DOI] [PubMed] [Google Scholar]
  • 43. Higashi DL, Lee SW, Snyder A, Weyand NJ, Bakke A, So M. Dynamics of Neisseria gonorrhoeae attachment: microcolony development, cortical plaque formation, and cytoprotection. Infect Immun 2007; 75:4743–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Merz AJ, So M. Attachment of piliated, Opa- and Opc- gonococci and meningococci to epithelial cells elicits cortical actin rearrangements and clustering of tyrosine-phosphorylated proteins. Infect Immun 1997; 65:4341–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Merz AJ, Enns CA, So M. Type IV pili of pathogenic Neisseriae elicit cortical plaque formation in epithelial cells. Mol Microbiol 1999; 32:1316–32. [DOI] [PubMed] [Google Scholar]
  • 46. Dietrich M, Bartfeld S, Munke R, et al. Activation of NF-kappaB by Neisseria gonorrhoeae is associated with microcolony formation and type IV pilus retraction. Cell Microbiol 2011; 13:1168–82. [DOI] [PubMed] [Google Scholar]
  • 47. Anderson MT, Dewenter L, Maier B, Seifert HS. Seminal plasma initiates a Neisseria gonorrhoeae transmission state. MBio 2014; 5:e01004–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Mikaty G, Soyer M, Mairey E, et al. Extracellular bacterial pathogen induces host cell surface reorganization to resist shear stress. PLoS Pathog 2009; 5:e1000314. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

jiz628_suppl_Supplementary_Materials
Click here for additional data file. (3.3MB, pdf)

Articles from The Journal of Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES